- Drug Spotlight, Drugs Programmes, Home Featured
Implementation of ICH Q1 and Q7 Guidelines
- Home Featured, Press Release
Emergency use authorization of the Mpox vaccine by NAFDAC: A crucial step in Nigeria’s public health response
- Home Featured
NAFDAC Traceability: Find out all you need to know here
- Home Featured, Vaccine Publications
Vaccine Types And Benefits: What You Need To Know
- Home Featured, Press Release
Approval by NAFDAC on use of Gardasil Vaccine as Single Dose in the Routine Immunization
Gardasil is a vaccine that protects against human papillomavirus (HPV), a common sexually transmitted infection that can cause cervical, vaginal, vulvar, and other cancers.
Recalls & Safety Alerts
The list below are recalls and alert released by NAFDAC. The alert notices and safety communication contain safety measures to be taken and information that may impact both treatment and diagnostic choices for healthcare providers and patients.
Our Services
Meet the Director General.
Prof Moji Adeyeye is the Director General of National Agency for Food and Drug Administration and Control (NAFDAC) where she has added strong governance structure, regulatory system strengthening, and strengthening of the local pharmaceutical companies through international best practices with emphasis on local manufacturing.
Prof. Moji Christianah Adeyeye
Director General, NAFDAC
